Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hartman

Showing results (361-370 of 459) with videos related to

Pageof 46
Sort By:
Breast Cancer Research and Treatment|January 1, 1996
Farnesyltransferase inhibitors and anti-Ras therapyJ B Gibbs, N E Kohl, K S Koblan, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft modelMark T Bilodeau, Adrienne E Balitza, Jacob M Hoffman, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferaseC J Dinsmore, T M Williams, T J O'Neill, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Identification of non-amidine inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferaseT M Ciccarone, S C MacTough, T M Williams, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitorsZhijian Zhao, William H Leister, Julie A O'Brien, et al.
Journal of Medicinal Chemistry|June 21, 2011
Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffoldScott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 10: In vitro and in vivo evaluation of a potent 7-methyl substituted tetrahydro-[1,8]naphthyridine derivativeMichael J Breslin, Mark E Duggan, Wasyl Halczenko, et al.
Ecological Applications : a Publication of the Ecological Society of America|May 10, 2024
Secondary production of the central rangeland region of the United StatesEdward J Raynor, Justin D Derner, Melannie D Hartman, et al.
Biofactors (Oxford, England)|January 1, 1997
Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growthC A Omer, N J Anthony, C A Buser-Doepner, et al.
Pageof 46

Showing results (361-370 of 459) with videos related to

Sort By:
Pageof 46
Breast Cancer Research and Treatment|January 1, 1996
Farnesyltransferase inhibitors and anti-Ras therapyJ B Gibbs, N E Kohl, K S Koblan, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft modelMark T Bilodeau, Adrienne E Balitza, Jacob M Hoffman, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferaseC J Dinsmore, T M Williams, T J O'Neill, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Identification of non-amidine inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferaseT M Ciccarone, S C MacTough, T M Williams, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitorsZhijian Zhao, William H Leister, Julie A O'Brien, et al.
Journal of Medicinal Chemistry|June 21, 2011
Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffoldScott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 10: In vitro and in vivo evaluation of a potent 7-methyl substituted tetrahydro-[1,8]naphthyridine derivativeMichael J Breslin, Mark E Duggan, Wasyl Halczenko, et al.
Ecological Applications : a Publication of the Ecological Society of America|May 10, 2024
Secondary production of the central rangeland region of the United StatesEdward J Raynor, Justin D Derner, Melannie D Hartman, et al.
Biofactors (Oxford, England)|January 1, 1997
Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growthC A Omer, N J Anthony, C A Buser-Doepner, et al.
Pageof 46